$76.08 +4.57 (%) Clovis Oncology Inc - NASDAQ

Aug. 27, 2015 | 04:00 PM

Partner Headlines

  1. Clovis Oncology Completes US, EU Regulatory Submissions for Rociletinib for Treatment of Advanced EGFR-Mutant T790M+ NSCLC

    Benzinga | Aug. 3, 2015 | 06:03AM EST
  2. Benzinga's Top Upgrades

    Benzinga | Jul. 20, 2015 | 09:14AM EST
  3. Clovis Oncology Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

    Benzinga | Jul. 10, 2015 | 06:01AM EST
  4. Clovis Oncology Initiates Rolling NDA Submission to the FDA for Rociletinib in the Treatment of Advanced EGFR-Mutant Non-small Cell Lung Cancer

    Benzinga | Jul. 1, 2015 | 16:06PM EST
  5. Morning Market Losers

    Benzinga | Jun. 1, 2015 | 10:25AM EST
  6. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus | Apr. 14, 2015 | 21:01PM EST
  7. Clovis Technology Gets Big Boost From Goldman Upgrade

    IBD | Apr. 13, 2015 | 16:06PM EST
  8. Benzinga's Volume Movers

    Benzinga | Apr. 13, 2015 | 10:25AM EST
  9. Morning Market Gainers

    Benzinga | Apr. 13, 2015 | 09:41AM EST
  10. Benzinga's Top Upgrades

    Benzinga | Apr. 13, 2015 | 09:08AM EST
  11. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 13, 2015 | 08:12AM EST
  12. Goldman Sachs Upgrades Clovis Oncology To Buy

    Benzinga | Apr. 13, 2015 | 07:45AM EST
  13. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  15. Morning Market Losers

    Benzinga | Nov. 19, 2014 | 09:53AM EST
  16. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration With GlaxoSmithKline

    Benzinga | Nov. 17, 2014 | 17:00PM EST
  17. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga | Nov. 7, 2014 | 08:33AM EST
  18. Morning Market Losers

    Benzinga | Sep. 3, 2014 | 09:50AM EST
  19. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga | Jul. 18, 2014 | 15:40PM EST
  20. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga | Jun. 23, 2014 | 07:41AM EST
  21. Market Wrap For June 5: Markets Positive Before Friday's Employment Report

    Benzinga | Jun. 5, 2014 | 16:35PM EST
  22. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga | Jun. 5, 2014 | 10:38AM EST
  23. Market Wrap For June 4: Markets Slightly Higher On Light Volume, Beige Book

    Benzinga | Jun. 4, 2014 | 16:38PM EST
  24. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga | Jun. 4, 2014 | 08:32AM EST
  25. Benzinga's Volume Movers

    Benzinga | Mar. 27, 2014 | 10:34AM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 27, 2014 | 08:20AM EST
  27. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive Phase 1 Trial Results for NSCLC Treatment

    Benzinga | Mar. 27, 2014 | 07:54AM EST
  28. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga | Mar. 27, 2014 | 07:33AM EST
  29. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues Downbeat Q1 Forecast

    Benzinga | Mar. 26, 2014 | 10:24AM EST
  30. Benzinga's Top Initiations

    Benzinga | Mar. 24, 2014 | 08:21AM EST
  31. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares Spike Higher

    Benzinga | Jan. 13, 2014 | 12:52PM EST
  32. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook

    Benzinga | Jan. 13, 2014 | 10:39AM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 13, 2014 | 08:21AM EST
  34. Clovis Oncology Announces 2014 Objectives, Financial Guidance

    Benzinga | Jan. 13, 2014 | 07:34AM EST
  35. What The Top Stocks Of 2013 Had In Common

    IBD | Dec. 31, 2013 | 18:35PM EST
  36. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation at 2014 ELCC

    Benzinga | Dec. 23, 2013 | 06:07AM EST
  37. Clovis Oncology Announces 2M Share Offering by Selling Stockholders

    Benzinga | Dec. 2, 2013 | 16:09PM EST
  38. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga | Nov. 19, 2013 | 17:58PM EST
  39. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga | Nov. 19, 2013 | 15:28PM EST
  40. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects Of CO-1686

    Benzinga | Nov. 15, 2013 | 08:18AM EST
  41. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates

    Benzinga | Oct. 28, 2013 | 10:35AM EST
  42. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity and Safety in Phase I Study

    Benzinga | Oct. 27, 2013 | 19:36PM EST
  43. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD | Oct. 22, 2013 | 10:44AM EST
  44. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations

    Benzinga | Oct. 21, 2013 | 16:02PM EST
  45. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network Shares Jump

    Benzinga | Sep. 30, 2013 | 13:12PM EST
  46. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net Profit Declines 7%

    Benzinga | Sep. 30, 2013 | 10:31AM EST
  47. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares Surge On Acquisition News

    Benzinga | Sep. 25, 2013 | 12:55PM EST
  48. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit Rises 15%

    Benzinga | Sep. 25, 2013 | 10:31AM EST
  49. Morning Market Losers

    Benzinga | Sep. 25, 2013 | 09:56AM EST
  50. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga | Sep. 24, 2013 | 17:18PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!